Provenienza dei contatti di primo grado di Leo de Leede
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
InGell Labs BV
InGell Labs BV Pharmaceuticals: MajorHealth Technology InGell Labs BV develops polymer-based injectable hydrogels for drug delivery. The firm’s products include InGell LQP, Ingell Gamma, and running in-house projects. It offers its bioabsorbable injectable hydrogel systems for reducing side-effects and localization of novel therapies to life-cycle management opportunities. The company was founded by Paul van Midwoud, Theodorus Adrianus Cornelius Flipsen, Mike G. de Leeuw, and Jan P. M. Hendriks in 2010 and is headquartered in Groningen, the Netherlands.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Leo de Leede tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
InnoCore Technologies BV
InnoCore Technologies BV Pharmaceuticals: MajorHealth Technology InnoCore Technologies BV develops drug delivery technologies. It serves the pharmaceutical and medical device industry by developing and manufacturing innovative drug delivery systems that enhance their products. The company was founded by Theodorus Adrianus Cornelius Flipsen and Rob Steendam in 2004 and is headquartered in Groningen, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
Xenikos BV
Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member | |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Biotechnology | Founder | |
Alvotech Germany GmbH
Alvotech Germany GmbH BiotechnologyHealth Technology Baliopharm GmbH operates as biotechnology company. It develops a novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer. The company was founded in 2011 and is headquartered in Juelich, Germany. | Biotechnology | Director/Board Member | |
Pharma Connect Capital
Pharma Connect Capital Investment ManagersFinance Pharma Connect Capital BV is a private equity firm with headquarters in Groningen, the Netherlands. It was founded in 2017. | Investment Managers | Private Equity Investor | |
University of Leiden | College/University | Doctorate Degree | |
PolyVation BV
PolyVation BV Miscellaneous Commercial ServicesCommercial Services PolyVation BV provides research, development, custom synthesis, and manufacturing services relating to polymers for biomedical and pharmaceutical applications. The firm performs biocompatibility research such as review, planning, rationales, physico-chemical, and biological tests. It also offers vinyl pyrolidone, acrylate, and silicone. The company was founded by Theodorus Adrianus Cornelius Flipsen in 1996 and is headquartered in Groningen, the Netherlands. | Miscellaneous Commercial Services | Chief Executive Officer | |
Polyganics BV
Polyganics BV Medical SpecialtiesHealth Technology Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands. | Medical Specialties | Founder | |
Neurendo BV
Neurendo BV Medical SpecialtiesHealth Technology Neurendo BV develops novel polymer-based trocars. Its products are used in neuro surgical procedures. The firm provides shafts which are used to fix skulls. The company is headquartered in Groningen, the Netherlands. | Medical Specialties | Chief Executive Officer |
Statistiche
Distribuzione geografica
Paesi Bassi | 9 |
Germania | 3 |
Settori
Health Technology | 7 |
Commercial Services | 3 |
Finance | 2 |
Consumer Services | 2 |
Posizioni
Founder | 8 |
Chief Executive Officer | 5 |
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
President | 3 |
Contatti più connessi
- Borsa valori
- Insiders
- Leo de Leede
- Connessioni Società